Also among HER2-amplified carcinomas (n = 92), older age and inflammatory disease predicted BCM (HR 3.7, CI 1.2–12.0, p = 0.03 and HR 7.2, CI 2.0–25.8, p = 0.003, respectively). This evidence concerns the gene ERBB2 and carcinoma.